Oxford Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-443,962
| Closed | -$1.84M | – | 819 |
|
|
2019
Q4 | $1.84M | Buy |
+443,962
| New | +$1.84M | 0.05% | 468 |
|
|
2017
Q3 | – | Sell |
-104,837
| Closed | -$1.73M | – | 1629 |
|
|
2017
Q2 | $1.73M | Buy |
+104,837
| New | +$1.73M | 0.03% | 671 |
|
|
2016
Q4 | – | Sell |
-277,954
| Closed | -$5.02M | – | 831 |
|
|
2016
Q3 | $5.02M | Sell |
277,954
-109,429
| -28% | -$1.98M | 0.16% | 150 |
|
|
2016
Q2 | $5.56M | Buy |
387,383
+60,623
| +19% | +$870K | 0.18% | 128 |
|
|
2016
Q1 | $3.91M | Buy |
326,760
+222,783
| +214% | +$2.66M | 0.11% | 226 |
|
|
2015
Q4 | $1.39M | Sell |
103,977
-43,812
| -30% | -$586K | 0.03% | 462 |
|
|
2015
Q3 | $1.59M | Buy |
147,789
+43,164
| +41% | +$464K | 0.05% | 330 |
|
|
2015
Q2 | $842K | Buy |
+104,625
| New | +$842K | 0.02% | 466 |
|
|
2015
Q1 | – | Sell |
-11,101
| Closed | -$67K | – | 707 |
|
|
2014
Q4 | $67K | Buy |
+11,101
| New | +$67K | ﹤0.01% | 665 |
|